This inventor holds 1 USPTO granted patent. Top assignee: National Research Development Corporation. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Michael I Stockham: Innovator in Pharmaceutical Compositions
Introduction
Michael I Stockham is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of iron deficiency anemia. His innovative work has led to the development of a unique pharmaceutical composition that addresses this common health issue.
Latest Patents
Michael I Stockham holds a patent for pharmaceutical compositions containing an iron complex of 3-hydroxy-4-pyrone. This composition is particularly valuable as it includes a 3-hydroxy-4-pyrone in which one or more hydrogen atoms attached to ring carbon atoms are replaced by an aliphatic hydrocarbon group of 1 to 6 carbon atoms. This innovation plays a crucial role in the treatment of iron deficiency anemia, providing a new avenue for effective therapy.
Career Highlights
Throughout his career, Michael has been associated with the National Research Development Corporation. His work there has allowed him to focus on developing innovative solutions in the pharmaceutical sector. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Michael I Stockham has collaborated with esteemed colleagues such as Robert Charles Hider and George Kontoghiorghes. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in pharmaceutical research.
Conclusion
Michael I Stockham's contributions to pharmaceutical compositions demonstrate his commitment to addressing critical health challenges. His innovative patent and collaborative efforts highlight the importance of research in developing effective treatments for iron deficiency anemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
